13th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC)
In-Person Event
Nov 19 - 21, 2015
Universal City, California, USA
OVERVIEW
The World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC), now in its 13th year, is a unique and exciting multidisciplinary program, to be held this year in Universal City, California. The Congress is the premiere global meeting dedicated to diabetes, obesity, metabolism, and energy balance, linking research to clinical practice, and highlighting our theme — Exploring New Frontiers in Metabolism — Tomorrow’s Clinical Science Today.
Since Dr. Gerald Reaven’s pioneering work crystallized the relationship between insulin resistance (IR,) diabetes and cardiovascular disease (CVD), the Congress’ focus has been augmented by the role of obesity, fat cell, and inflammation, in furthering cardiometabolic conditions. The WCIRDC is a distinguished platform where the interaction of multiple metabolic systems, like circadian rhythm, sleep disturbances, the neuroendocrine system, the gut, related hormones, and their relationship to the brain, are evaluated in both the scientific and clinical environments. Ultimately the Congress is set on developing an innovative and comprehensive plan for managing CV risk factors and diseases.
The program is designed to evaluate both clinical and basic science aspects of diabetes, obesity, and CVD, focusing on insulin resistance, hyperinsulinemia, fat cell, incretins, the gut, the brain, the kidney and energy metabolism. The goal is to understand its pathophysiology, and to develop appropriate comprehensive clinical management plans.
This educational initiative is designed for cardiologists, endocrinologists, gastroenterologists, oncologists, family physicians, internists, diabetologists, OBGYNs, pediatricians, dieticians, nurse practitioners, pharmacists, and any other health care professional who is interested in insulin resistance, diabetes, obesity, and cardiovascular disease, and multiple metabolic mechanisms’ affect on health and society, as well as on potential treatment and prevention.
Since Dr. Gerald Reaven’s pioneering work crystallized the relationship between insulin resistance (IR,) diabetes and cardiovascular disease (CVD), the Congress’ focus has been augmented by the role of obesity, fat cell, and inflammation, in furthering cardiometabolic conditions. The WCIRDC is a distinguished platform where the interaction of multiple metabolic systems, like circadian rhythm, sleep disturbances, the neuroendocrine system, the gut, related hormones, and their relationship to the brain, are evaluated in both the scientific and clinical environments. Ultimately the Congress is set on developing an innovative and comprehensive plan for managing CV risk factors and diseases.
The program is designed to evaluate both clinical and basic science aspects of diabetes, obesity, and CVD, focusing on insulin resistance, hyperinsulinemia, fat cell, incretins, the gut, the brain, the kidney and energy metabolism. The goal is to understand its pathophysiology, and to develop appropriate comprehensive clinical management plans.
This educational initiative is designed for cardiologists, endocrinologists, gastroenterologists, oncologists, family physicians, internists, diabetologists, OBGYNs, pediatricians, dieticians, nurse practitioners, pharmacists, and any other health care professional who is interested in insulin resistance, diabetes, obesity, and cardiovascular disease, and multiple metabolic mechanisms’ affect on health and society, as well as on potential treatment and prevention.
KEY DATES
19 Nov, 2015
Event Start Date
21 Nov, 2015
Event End Date
SPECIALITIES
CardiologyEndocrinology, Metabolism and DiabetesSUGGESTED HOTELS
CONFERENCE VENUE
Hilton Los Angeles/Universal CityRELATED CONFERENCES & LIVE WEBINARS
Quick Links